Clinical Trials · NCT06980623
Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
- Phase
- N/A
- Recruitment status
- Active Not Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 26,000
- Start date
- Jan 2025
- Locations
- 1 site, United States
- Primary endpoint
- Hospitalization for heart failure and all-cause mortality